Meta-analysis finds education lowers DVT risk after orthopedic surgery
Teaching patients about DVT cuts risk after orthopedic surgery
This meta-analysis of six studies in orthopedic surgery patients found that education-based interventions were associated with a significant…
A review of studies finds that educating patients about deep vein thrombosis after orthopedic surgery can significantly lower their risk of …
External validation of three DVT prediction models in 1,270 acute stroke patients.
Three DVT prediction models showed varying accuracy in a single-center stroke study.
This single-center spatial validation cohort study assessed three deep vein thrombosis (DVT) prediction models in 1,270 patients with acute …
The Lu Qiufang model outperformed others with 82.1% accuracy in predicting deep vein thrombosis among 1,270 acute stroke patients at a Shenz…
Asthma associated with increased odds of venous thromboembolism, pulmonary embolism, and deep vein thrombosis in observational studies.
Asthma Linked to Higher Risk of Blood Clots in Observational Data
This meta-analysis of observational studies involving patients with asthma found a statistically significant association between asthma and …
People with asthma face a 1.61 times higher risk of blood clots, with the danger of pulmonary embolism rising 2.41 times and deep vein throm…
Regional anesthesia with propofol sedation versus general anesthesia in unilateral total knee arthroplasty patients.
Numb Legs, Faster Walks: New Knee Surgery Data
This retrospective cohort study evaluated 250 patients undergoing unilateral total knee arthroplasty to compare regional anesthesia with mon…
New knee surgery data shows regional anesthesia leads to faster walking and fewer readmissions without increasing dangerous blood clot risk.
FDA Approves Xarelto (rivaroxaban) for multiple indications including stroke prevention in nonvalvular atrial fibrillation and treatment of VTE.
FDA approves a new blood thinner called Xarelto for several heart and clot conditions.
The FDA approved rivaroxaban (Xarelto), a factor Xa inhibitor, for multiple indications including reducing stroke risk in nonvalvular atrial…
FDA approves new blood thinner Xarelto to prevent dangerous clots in heart conditions, deep vein issues, and after major surgeries.